BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 21854747)

  • 21. New screening system using Twist1 promoter activity identifies dihydrorotenone as a potent drug targeting cancer-associated fibroblasts.
    Lee E; Yeo SY; Lee KW; Lee JA; Kim KK; Kim SH
    Sci Rep; 2020 Apr; 10(1):7058. PubMed ID: 32341496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EMP3 is induced by TWIST1/2 and regulates epithelial-to-mesenchymal transition of gastric cancer cells.
    Han M; Xu W
    Tumour Biol; 2017 Jul; 39(7):1010428317718404. PubMed ID: 28718375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TWIST1 upregulates miR-214 to promote epithelial-to-mesenchymal transition and metastasis in lung adenocarcinoma.
    Liu C; Luo J; Zhao YT; Wang ZY; Zhou J; Huang S; Huang JN; Long HX; Zhu B
    Int J Mol Med; 2018 Jul; 42(1):461-470. PubMed ID: 29693173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of targets of Twist1 transcription factor in thyroid cancer cells.
    Di Maro G; Orlandella FM; Bencivenga TC; Salerno P; Ugolini C; Basolo F; Maestro R; Salvatore G
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1617-26. PubMed ID: 24848707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of Twist1-mediated invasion by Chk2 promotes premature senescence in p53-defective cancer cells.
    Nayak D; Kumar A; Chakraborty S; Rasool RU; Amin H; Katoch A; Gopinath V; Mahajan V; Zilla MK; Rah B; Gandhi SG; Ali A; Kumar LD; Goswami A
    Cell Death Differ; 2017 Jul; 24(7):1275-1287. PubMed ID: 28498365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KLF11 promotes gastric cancer invasion and migration by increasing Twist1 expression.
    Ji Q; Li Y; Zhao Q; Fan LQ; Tan BB; Zhang ZD; Zhao XF; Liu Y; Wang D; Jia N
    Neoplasma; 2019 Jan; 66(1):92-100. PubMed ID: 30509092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual role of twist1 in cancer-associated fibroblasts and tumor cells promoted epithelial-mesenchymal transition of esophageal cancer.
    Zhu X; Han S; Wu S; Bai Y; Zhang N; Wei L
    Exp Cell Res; 2019 Feb; 375(2):41-50. PubMed ID: 30611739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA Methylation in the Exon 1 Region and Complex Regulation of Twist1 Expression in Gastric Cancer Cells.
    Sakamoto A; Akiyama Y; Shimada S; Zhu WG; Yuasa Y; Tanaka S
    PLoS One; 2015; 10(12):e0145630. PubMed ID: 26695186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ARTEMIN synergizes with TWIST1 to promote metastasis and poor survival outcome in patients with ER negative mammary carcinoma.
    Banerjee A; Wu ZS; Qian P; Kang J; Pandey V; Liu DX; Zhu T; Lobie PE
    Breast Cancer Res; 2011; 13(6):R112. PubMed ID: 22060274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HMGA2 promotes vasculogenic mimicry and tumor aggressiveness by upregulating Twist1 in gastric carcinoma.
    Sun J; Sun B; Sun R; Zhu D; Zhao X; Zhang Y; Dong X; Che N; Li J; Liu F; Zhao N; Wang Y; Zhang D
    Sci Rep; 2017 May; 7(1):2229. PubMed ID: 28533522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ETS2 and Twist1 promote invasiveness of Helicobacter pylori-infected gastric cancer cells by inducing Siah2.
    Das L; Kokate SB; Rath S; Rout N; Singh SP; Crowe SE; Mukhopadhyay AK; Bhattacharyya A
    Biochem J; 2016 Jun; 473(11):1629-40. PubMed ID: 27048589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TWIST1 is expressed in colorectal carcinomas and predicts patient survival.
    Gomez I; Peña C; Herrera M; Muñoz C; Larriba MJ; Garcia V; Dominguez G; Silva J; Rodriguez R; Garcia de Herreros A; Bonilla F; Garcia JM
    PLoS One; 2011 Mar; 6(3):e18023. PubMed ID: 21464926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High SRC-1 and Twist1 expression predicts poor prognosis and promotes migration and invasion by inducing epithelial-mesenchymal transition in human nasopharyngeal carcinoma.
    Zhou J; Zhang J; Xu M; Ke Z; Zhang W; Mai J
    PLoS One; 2019; 14(4):e0215299. PubMed ID: 30973923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TWIST1 promoter methylation in primary colorectal carcinoma.
    Ruppenthal RD; Nicolini C; Filho AF; Meurer R; Damin AP; Rohe A; Alexandre CO; Damin DC
    Pathol Oncol Res; 2011 Dec; 17(4):867-72. PubMed ID: 21461979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1.
    Li LZ; Zhang CZ; Liu LL; Yi C; Lu SX; Zhou X; Zhang ZJ; Peng YH; Yang YZ; Yun JP
    Carcinogenesis; 2014 Feb; 35(2):469-78. PubMed ID: 24085799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
    Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
    J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TWIST1 promoter methylation is associated with prognosis in tonsillar squamous cell carcinoma.
    Kwon MJ; Kwon JH; Nam ES; Shin HS; Lee DJ; Kim JH; Rho YS; Sung CO; Lee WJ; Cho SJ
    Hum Pathol; 2013 Sep; 44(9):1722-9. PubMed ID: 23664538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. lncRNA JPX/miR-33a-5p/Twist1 axis regulates tumorigenesis and metastasis of lung cancer by activating Wnt/β-catenin signaling.
    Pan J; Fang S; Tian H; Zhou C; Zhao X; Tian H; He J; Shen W; Meng X; Jin X; Gong Z
    Mol Cancer; 2020 Jan; 19(1):9. PubMed ID: 31941509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CADM1 is a TWIST1-regulated suppressor of invasion and survival.
    Hartsough EJ; Weiss MB; Heilman SA; Purwin TJ; Kugel CH; Rosenbaum SR; Erkes DA; Tiago M; HooKim K; Chervoneva I; Aplin AE
    Cell Death Dis; 2019 Mar; 10(4):281. PubMed ID: 30911007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Novel Oxoglutarate Dehydrogenase-Like Mediated miR-214/TWIST1 Negative Feedback Loop Inhibits Pancreatic Cancer Growth and Metastasis.
    Liu Y; Meng F; Wang J; Liu M; Yang G; Song R; Zheng T; Liang Y; Zhang S; Yin D; Wang J; Yang H; Pan S; Sun B; Han J; Sun J; Lan Y; Wang Y; Liu X; Zhu M; Cui Y; Zhang B; Wu D; Liang S; Liu Y; Song X; Lu Z; Yang J; Li M; Liu L
    Clin Cancer Res; 2019 Sep; 25(17):5407-5421. PubMed ID: 31175094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.